13 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has declined 42.0% per year over the past 5 years.
Operating margin has contracted, at -8761.1% in the latest year.
Financial health
Operating income covered interest expense -1261.6× in the latest year.
The company is unprofitable; at its current free-cash-flow burn it has roughly 1.2 years of cash runway.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$144000
-$2M
96.5%
-8761.1%
-$9M
—
$11M
2024
$109000
-$15M
0.0%
-13840.4%
-$15M
—
$3M
2023
$370000
-$17M
0.0%
-4792.2%
-$13M
—
$15M
2022
$2M
-$11M
0.0%
-765.3%
-$9M
—
$29M
2021
$0
-$17M
—
—
-$14M
—
$37M
2020
$2M
-$19M
85.1%
-977.9%
-$15M
—
$27M
2019
$3M
-$27M
84.4%
-882.4%
-$20M
—
$36M
2018
$5M
-$35M
77.6%
-766.3%
-$29M
—
$44M
2017
—
-$38M
—
—
—
—
$63M
2016
—
-$39M
—
—
—
—
$62M
2015
—
-$30M
—
—
—
—
$50M
2014
—
-$26M
—
—
-$16M
—
$48M
2012
—
-$44M
—
—
-$10M
—
$15M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Dec '25
$26000
-$3M
100.0%
-10576.9%
-$2M
—
$4M
Sep '25
$28000
-$3M
100.0%
-9410.7%
—
—
$7M
Jun '25
$37000
-$3M
100.0%
-7878.4%
—
—
$9M
Mar '25
$51000
$7M
100.0%
-6184.3%
-$2M
—
$11M
Dec '24
$24000
-$3M
91.7%
-14450.0%
-$2M
—
$1M
Sep '24
$30000
-$3M
96.7%
-8693.3%
-$3M
—
$3M
Jun '24
$39000
-$3M
94.9%
-8682.1%
-$3M
—
$6M
Mar '24
$29000
-$3M
0.0%
-10675.9%
-$3M
—
$3M
Dec '23
$5000
-$4M
100.0%
-73600.0%
-$4M
—
$5M
Sep '23
$0
-$4M
—
—
-$3M
—
$8M
Jun '23
$75000
-$4M
100.0%
-5593.3%
-$5M
—
$11M
Mar '23
$162000
-$7M
0.0%
-4801.9%
-$5M
—
$15M
Dec '22
$131000
-$3M
0.0%
-2564.1%
-$3M
—
$20M
Sep '22
$77000
-$3M
0.0%
-4355.8%
-$2M
—
$13M
Jun '22
$0
-$3M
—
—
-$2M
—
$16M
Mar '22
$2M
-$2M
0.0%
-127.5%
-$2M
—
$29M
Dec '21
$0
-$4M
—
—
-$3M
—
$30M
Sep '21
$0
-$4M
—
—
-$2M
—
$34M
Jun '21
—
-$3M
—
—
-$2M
—
$36M
Mar '21
$0
-$3M
—
—
-$2M
—
$37M
Valuation over time
How the market has priced VIVS against its own fundamentals since 2025-04 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-sales ratio has fallen from 35.5× (Apr '25) to 19.9× (Jun '26).
Price / sales (P/S)
P/S
Frequently asked questions
Is VIVS growing its revenue and profit?
Over the past 5 years, VivoSim Labs, INC.'s revenue has declined 42.0% per year. These are computed facts, not advice.
How much debt does VIVS have?
As of FY2025, VivoSim Labs, INC. reported — of total debt against $11M of cash; operating income covered interest expense -1261.6×.
What is VIVS's profit margin?
In FY2025, gross margin was 96.5%, operating margin -8761.1%, and net margin -1727.8%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.